These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2974466)

  • 1. The human immunodeficiency virus and its pathogenesis.
    Levy JA
    Infect Dis Clin North Am; 1988 Jun; 2(2):285-97. PubMed ID: 2974466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV pathogenesis and intrinsic cellular defense mechanisms].
    Suzuki Y; Suzuki Y
    Nihon Rinsho; 2010 Mar; 68(3):415-21. PubMed ID: 20229783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus evolution within patients increases pathogenicity.
    Iwasa Y; Michor F; Nowak MA
    J Theor Biol; 2005 Jan; 232(1):17-26. PubMed ID: 15498589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
    Cohen DE; Walker BD
    Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.
    Kilby JM
    Clin Infect Dis; 2001 Sep; 33(6):873-84. PubMed ID: 11512093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of immune suppression in AIDS: possibilities of prevention.
    Gluckman JC; Klatzmann D
    Cancer Detect Prev; 1988; 12(1-6):175-80. PubMed ID: 3052831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maedi-visna virus and its relationship to human immunodeficiency virus.
    Thormar H
    AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of human immunodeficiency virus.
    Ahsan N; Langhoff E
    Semin Nephrol; 1998 Jul; 18(4):422-35. PubMed ID: 9692354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?].
    Zinkernagel R
    Verh Dtsch Ges Pathol; 1994; 78():166-70. PubMed ID: 7533980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?
    Walker BD
    AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunization against the human immunodeficiency virus in Zaire].
    Zagury D; Salaün JJ; Bernard J; Dechazal L; Goussard B; Lurhuma Z
    Med Trop (Mars); 1988; 48(4):417-23. PubMed ID: 3221792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of T cell immune responses in HIV-infected children from Uganda.
    Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
    J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the mechanisms and limitations of immune control of HIV.
    Davenport MP; Ribeiro RM; Zhang L; Wilson DP; Perelson AS
    Immunol Rev; 2007 Apr; 216():164-75. PubMed ID: 17367342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.
    Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ
    J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodeficiency virus exploitation of dendritic cells in the early steps of infection.
    Teleshova N; Frank I; Pope M
    J Leukoc Biol; 2003 Nov; 74(5):683-90. PubMed ID: 12960236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.